Tag: Cancer: Mouth
Time to Tx Initiation Impacts Survival in Head, Neck Cancer
Lower overall survival for time to treatment initiation of more than 46 to 52 days
Suicide Risk Up for Head, Neck Cancer Patients
Dependence on breathing tubes, feeding tubes might play a part in despair
Loss of Heterozygosity Validated As Marker for Oral Cancer
EGFR inhibitor erlotinib doesn't improve cancer-free survival in high-risk LOH-positive patients
Neuromuscular Stimulation Doesn’t Aid Dysphagia Patients
Combining NMES with swallow exercises in head and neck cancer patients not helpful
Statistical Tool Predicts Risk of Major Post-Op Complications
Tool validated in patients treated for oral cavity squamous cell carcinoma
High-Dose Hypofractionated RT Palliative in Head, Neck Cancer
Meaningful palliative effect for 63 percent of patients, lasting for median of 4.6 months
No Specific Findings to ID Recurrence in Head and Neck CA
No definite index of symptoms or signs indicating local recurrence, second primary malignancy
Metformin Linked to Lower Risk of Head, Neck Cancer
Diabetes patients treated with the drug less likely to develop oropharyngeal, nasopharyngeal cancers
Veterans Have Poor Oral, Throat Cancer Outcomes
In oropharyngeal squamous cell carcinoma, overall survival at five years is 40 percent
Blood, Saliva Tests May Help ID Head and Neck Cancers Early
Study shows potential for noninvasive tumor detection
